Company intelligence / Profile preview
Re-Vana Therapeutics
Belfast, Northern Ireland, United Kingdomrevanatx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Re-Vana has demonstrated that its proprietary platforms can achieve six months or greater sustained delivery of anti‑VEGF biologics with high drug loading and controlled burst release. Key nonclinical safety, tolerability, and efficacy studies have been successfully completed. The company’s technology enables office-based administration and aims to reduce the frequency of intravitreal injections required for major retinal diseases.[3][4][5]
- Therapeutic areas
- Ophthalmology
- Modalities
- Biologics (e.g., anti-VEGF therapies)Small molecules (e.g., prostaglandins, tyrosine kinase inhibitors)Peptides[1][5][6]Nitric oxide-donating compounds[8]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Nicox SA – research collaboration on nitric oxide-donor drugs using EyeLief™ platform for glaucoma/intraocular pressure reduction [8]Cambridge Design Partnership – device development partner for OcuLief® formulation [9]Multiple undisclosed global pharmaceutical companies conducting feasibility/preformulation studies [1]
Beyond the preview
Go deeper on Re-Vana Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Re-Vana Therapeutics.